Cadrenal Therapeutics Inc...

NASDAQ: CVKD · Real-Time Price · USD
16.72
0.22 (1.33%)
At close: May 02, 2025, 3:59 PM
17.01
1.73%
After-hours: May 02, 2025, 05:05 PM EDT

Cadrenal Therapeutics Common Stock Revenue

Cadrenal Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, Cadrenal Therapeutics Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
4
Market Cap
32.44M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.